Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L GELLER

Showing results (311-320 of 489) with videos related to

Pageof 49
Sort By:
Cancer|October 15, 1990
Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapyN L Geller, T B Hakes, G R Petroni, et al.
Immunology Today|October 26, 2014
The stepwise activation of cytotoxic T lymphocytesG Gromo, L Inverardi, R L Geller, et al.
Nucleic Acids Research|February 27, 2001
PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotypingM Beaulieu, G P Larson, L Geller, et al.
Human Heredity|April 2, 2005
On averaging power for genetic association and linkage studiesGang Zheng, Jungnam Joo, Santhi K Ganesh, et al.
American Journal of Ophthalmology|November 30, 1999
Cost considerations of medical therapy for glaucomaR G Fiscella, J L Geller, L L Gryz, et al.
Seminars in Oncology|October 1, 1990
Can we combine available data to evaluate the effects of neoadjuvant chemotherapy for invasive bladder cancer?N L Geller, H I Scher, M K Parmar, et al.
Research in Nursing & Health|March 1, 1981
Catheter management programs and postoperative urinary dysfunctionM T Oberst, D Graham, N L Geller, et al.
Cancer Research|September 15, 1990
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumorsG C Toner, N L Geller, C Tan, et al.
The American Journal of Psychiatry|August 1, 1990
Second-generation deinstitutionalization, I: The impact of Brewster v. Dukakis on state hospital case mixJ L Geller, W H Fisher, J L Wirth-Cauchon, et al.
Annals of the New York Academy of Sciences|June 9, 1998
Use of an immunoisolation device for cell transplantation and tumor immunotherapyR L Geller, T Loudovaris, S Neuenfeldt, et al.
Pageof 49

Showing results (311-320 of 489) with videos related to

Sort By:
Pageof 49
Cancer|October 15, 1990
Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapyN L Geller, T B Hakes, G R Petroni, et al.
Immunology Today|October 26, 2014
The stepwise activation of cytotoxic T lymphocytesG Gromo, L Inverardi, R L Geller, et al.
Nucleic Acids Research|February 27, 2001
PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotypingM Beaulieu, G P Larson, L Geller, et al.
Human Heredity|April 2, 2005
On averaging power for genetic association and linkage studiesGang Zheng, Jungnam Joo, Santhi K Ganesh, et al.
American Journal of Ophthalmology|November 30, 1999
Cost considerations of medical therapy for glaucomaR G Fiscella, J L Geller, L L Gryz, et al.
Seminars in Oncology|October 1, 1990
Can we combine available data to evaluate the effects of neoadjuvant chemotherapy for invasive bladder cancer?N L Geller, H I Scher, M K Parmar, et al.
Research in Nursing & Health|March 1, 1981
Catheter management programs and postoperative urinary dysfunctionM T Oberst, D Graham, N L Geller, et al.
Cancer Research|September 15, 1990
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumorsG C Toner, N L Geller, C Tan, et al.
The American Journal of Psychiatry|August 1, 1990
Second-generation deinstitutionalization, I: The impact of Brewster v. Dukakis on state hospital case mixJ L Geller, W H Fisher, J L Wirth-Cauchon, et al.
Annals of the New York Academy of Sciences|June 9, 1998
Use of an immunoisolation device for cell transplantation and tumor immunotherapyR L Geller, T Loudovaris, S Neuenfeldt, et al.
Pageof 49